The American Statistical Association, in collaboration with the Biopharmaceutical Statistics Section and US Food and Drug Administration Oncology Center of Excellence, offers the oncology educational fellowship designed for senior graduate students and postdocs.
drug development
Statisticians’ Future in the Pharmaceutical Industry: From Data Analysts to Strategic Partners
Today’s statisticians are stepping more into the spotlight, helping shape actual decisions that drive drug development forward—from early discovery through regulatory hurdles and beyond.
Registration Open for Symposium on AI in Pharmaceutical Medicine
The symposium, which can be attended in person or virtually, will take place June 10–11 at the Northeastern University campus in Boston with the theme Generative AI in Medical Research and Drug Development: Hype or Reality?
Orange County Chapter to Host Fall Biostatistics Symposium
The Orange County Chapter will host the 2023 Annual Orange County Biostatistics Symposium September 29–30. The theme of the two-day symposium is “Innovative Designs in Expediting Drug and Device Development.”
Symposium on AI in Clinical Drug Development Provides Forum to Discuss Policy
The symposium brought together participants from the FDA, pharmaceutical industry, and major academic institutions to discuss policy implications of implementing artificial intelligence in clinical drug development.
To Get a PhD or Not to Get a PhD? Part 3
The ASA Committee on Applied Statisticians is giving you the experiences of four statisticians who took different paths after their master’s degrees. This month, Allison Florance explains why she found a master’s degree to be right for her.
Meet Sylva Collins, Director of the Office of Biostatistics, US Food and Drug Administration
Sylva Collins joined the FDA’s Office of Biostatistics in 2019 and has more than 30 years of drug development experience and biostatistics leadership.
ASA to Cosponsor AI in Clinical Drug Development Symposium in May
The Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development aims to advance the use of artificial intelligence (AI) in drug development and deployment.
Leading Large … or My Dinner with Dennis
This month’s column profiles a statistician who, in every sense of the word, has spent his life leading large: Dennis Gillings.